Sermorelin, a fragment of GHRH, was once approved for diagnosing and treating GH deficiency in children before commercial withdrawal. Small studies in older adults show IGF-1 changes but inconsistent functional benefits.
Key points
- Paediatric GH deficiency use is a defined medical context.
- Small ageing studies show hormonal changes with modest or inconsistent body-composition effects.
- 'Anti-ageing' claims exceed the evidence.
- Products sold online under this name have not been independently verified; label identity and concentration cannot be assumed.
What the literature shows
Walker reviewed sermorelin's clinical history, including its paediatric use and rationale in ageing.
Khorram and colleagues reported changes in GH, IGF-1 and some body-composition measures in a small group of older adults.
What remains unknown
- Long-term outcomes in healthy adults.
- Whether marketed products match pharmaceutical material.
Safety and monitoring implications
- GH-axis stimulation may affect glucose and fluid balance.
- Avoid treating 'anti-ageing' clinic marketing as evidence.
Cited literature
- 1.Walker RF. (2006). Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?. Clinical Interventions in Aging. Find on PubMed
- 2.Khorram O, Laughlin GA, Yen SS. (1997). Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. Journal of Clinical Endocrinology and Metabolism. Find on PubMed
Community reports
Anecdotal — not scientific evidence
Lived experience is valuable context and often surfaces problems before the literature does. It is also uncontrolled, unverified and subject to bias, so it never overrides published findings here.
Editorial evidence status
MixedCommunity discussion of this compound is widespread, but no independently verified reports were available for this analysis. Anecdotes have not been invented or treated as clinical evidence.
Buying Sermorelin in Australia: what to check first
APEDRA does not sell Sermorelin or any other product, and takes no commission from suppliers. If you are researching where to buy it, the biggest practical risk is not the compound itself but what is actually in the bottle: under-dosing, substitution with a different compound, and contamination are all documented in independent testing of online research chemicals.
- Ask for a batch-specific third-party lab report (HPLC/mass spectrometry), not a generic certificate.
- Check independent review platforms, not only reviews hosted on the seller's own site.
- Read the shipping, returns and refund policies before ordering.
- Be wary of prices far below the market or exaggerated results claims.
Compare Australian vendors independently · how we assess suppliers
Terms used here are defined in our glossary, and the evidence-grading scale explains what this analysis's grade means. If you believe something here is wrong, tell us.
This analysis is educational. It is not medical advice, a dosing recommendation, or an endorsement of use. Speak with a qualified medical practitioner about your circumstances.